320 related articles for article (PubMed ID: 29499855)
1. Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects.
D'Souza DC; Carson RE; Driesen N; Johannesen J; Ranganathan M; Krystal JH;
Biol Psychiatry; 2018 Sep; 84(6):413-421. PubMed ID: 29499855
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia.
Surti TS; Ranganathan M; Johannesen JK; Gueorguieva R; Deaso E; Kenney JG; Krystal JH; D'Souza DC
Schizophr Res; 2023 Jun; 256():36-43. PubMed ID: 37141764
[TBL] [Abstract][Full Text] [Related]
3. Glycine transporter inhibition reverses ketamine-induced working memory deficits.
Roberts BM; Shaffer CL; Seymour PA; Schmidt CJ; Williams GV; Castner SA
Neuroreport; 2010 Mar; 21(5):390-4. PubMed ID: 20186106
[TBL] [Abstract][Full Text] [Related]
4. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N
Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656
[TBL] [Abstract][Full Text] [Related]
5. Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primates.
Castner SA; Murthy NV; Ridler K; Herdon H; Roberts BM; Weinzimmer DP; Huang Y; Zheng MQ; Rabiner EA; Gunn RN; Carson RE; Williams GV; Laruelle M
Neuropsychopharmacology; 2014 Nov; 39(12):2742-9. PubMed ID: 24487737
[TBL] [Abstract][Full Text] [Related]
6. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
Manahan-Vaughan D; Wildförster V; Thomsen C
Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
[TBL] [Abstract][Full Text] [Related]
7. Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers.
Martin-Facklam M; Pizzagalli F; Zhou Y; Ostrowitzki S; Raymont V; Brašić JR; Parkar N; Umbricht D; Dannals RF; Goldwater R; Wong DF
Neuropsychopharmacology; 2013 Feb; 38(3):504-12. PubMed ID: 23132267
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the novel GlyT1 PET tracer [18F]MK-6577 in humans.
Joshi AD; Sanabria-Bohórquez SM; Bormans G; Koole M; De Hoon J; Van Hecken A; Depre M; De Lepeleire I; Van Laere K; Sur C; Hamill TG
Synapse; 2015 Jan; 69(1):33-40. PubMed ID: 25196464
[TBL] [Abstract][Full Text] [Related]
9. Glycine-induced long-term synaptic potentiation is mediated by the glycine transporter GLYT1.
Igartua I; Solís JM; Bustamante J
Neuropharmacology; 2007 Jun; 52(8):1586-95. PubMed ID: 17462677
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Glycine Transporter-1 Inhibitor Iclepertin (BI 425809) on Sensory Processing, Neural Network Function, and Cognition in Animal Models Related to Schizophrenia.
Rosenbrock H; Dorner-Ciossek C; Giovannini R; Schmid B; Schuelert N
J Pharmacol Exp Ther; 2022 Aug; 382(2):223-232. PubMed ID: 35661632
[No Abstract] [Full Text] [Related]
11. Quantification of the glycine transporter 1 in rhesus monkey brain using [18F]MK-6577 and a model-based input function.
Sanabria-Bohórquez SM; Joshi AD; Holahan M; Daneker L; Riffel K; Williams M; Li W; Cook JJ; Hamill TG
Neuroimage; 2012 Feb; 59(3):2589-99. PubMed ID: 21930214
[TBL] [Abstract][Full Text] [Related]
12. A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies.
Zeng Z; O'Brien JA; Lemaire W; O'Malley SS; Miller PJ; Zhao Z; Wallace MA; Raab C; Lindsley CW; Sur C; Williams DL
Nucl Med Biol; 2008 Apr; 35(3):315-25. PubMed ID: 18355687
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242.
Ranganathan M; DeMartinis N; Huguenel B; Gaudreault F; Bednar MM; Shaffer CL; Gupta S; Cahill J; Sherif MA; Mancuso J; Zumpano L; D'Souza DC
Mol Psychiatry; 2017 Nov; 22(11):1633-1640. PubMed ID: 28242871
[TBL] [Abstract][Full Text] [Related]
14. Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.
D'Souza DC; Singh N; Elander J; Carbuto M; Pittman B; Udo de Haes J; Sjogren M; Peeters P; Ranganathan M; Schipper J
Neuropsychopharmacology; 2012 Mar; 37(4):1036-46. PubMed ID: 22113087
[TBL] [Abstract][Full Text] [Related]
15. GlyT1 inhibitor reduces oscillatory potentials of the electroretinogram in rats.
Liu CN; Pettersen B; Seitis G; Osgood S; Somps C
Cutan Ocul Toxicol; 2014 Sep; 33(3):206-11. PubMed ID: 24147951
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography.
Borroni E; Zhou Y; Ostrowitzki S; Alberati D; Kumar A; Hainzl D; Hartung T; Hilton J; Dannals RF; Wong DF
Neuroimage; 2013 Jul; 75():291-300. PubMed ID: 22178811
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia.
Chaki S; Shimazaki T; Karasawa J; Aoki T; Kaku A; Iijima M; Kambe D; Yamamoto S; Kawakita Y; Shibata T; Abe K; Okubo T; Sekiguchi Y; Okuyama S
Psychopharmacology (Berl); 2015 Aug; 232(15):2849-61. PubMed ID: 25869273
[TBL] [Abstract][Full Text] [Related]
18. The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey.
Eddins D; Hamill TG; Puri V; Cannon CE; Vivian JA; Sanabria-Bohórquez SM; Cook JJ; Morrow JA; Thomson F; Uslaner JM
Psychopharmacology (Berl); 2014 Feb; 231(3):511-9. PubMed ID: 24051602
[TBL] [Abstract][Full Text] [Related]
19. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
[TBL] [Abstract][Full Text] [Related]
20. Pro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodents.
Deiana S; Hauber W; Munster A; Sommer S; Ferger B; Marti A; Schmid B; Dorner-Ciossek C; Rosenbrock H
Eur J Pharmacol; 2022 Nov; 935():175306. PubMed ID: 36183855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
